Topiramate IV: Enhanced Method of Administration in Babies, Older Children and Adults
PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Pipeline Type
New Formulations and Indications
Phase Of Development
Preclinical
Sponsors and Collaborators
University of Minnesota; Ligang Pharmaceuticals (formerly CyDex), EF
Mechanism of Action
Mechanism Description
Toprimate extended release
Populations Tested In
For those taking Topiramate who end up in hospital
Other Resources
Special FDA Designation
Nonprofit or Government Support
Nonprofit
Nonprofit or Government Support Description
Epilepsy Foundation - NTCG 2014
Previous Presentations
Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
N/A
Location of Clinical Trials
N/A
Clinical Trial link